BioSpace News Archive

Business

electroCore to Announce Second Quarter Financial Results on Wednesday, August 9

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the second quarter ended June 30, 2023, after the close of the market on Wednesday, August 9, 2023.

August 1, 2023
·
1 min read
Business

ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today announced that the company will report financial results for the three and six months ended June 30, 2023 on Monday, August 14, 2023 after the close of trading on the U.S. financial markets.

August 1, 2023
·
2 min read
Business

Gamida Cell to Report Second Quarter 2023 Financial Results

Gamida Cell Ltd. today announced that the company will release its financial results for the second quarter ended June 30, 2023 on Monday, August 14, 2023.

August 1, 2023
·
1 min read
Pharm Country

Aspargo Laboratories, Inc. Announces Filing of Its Investigational New Drug Application for Sildenafil Oral Spray

Aspargo Laboratories, Inc. announced that it has submitted an Investigational New Drug application, which has been accepted for review, to the U.S. Food and Drug Administration for ASP-001 in the treatment of erectile dysfunction.

August 1, 2023
·
5 min read
INmune Bio Inc. to Present at the BTIG Virtual Biotechnology Conference

INmune Bio announced today that RJ Tesi, MD, CEO and David Moss, Chief Financial Officer, will present a corporate overview at the BTIG Virtual Biotechnology Conference being held on August 7 – 8, 2023.

August 1, 2023
·
3 min read
FDA

Tyra Biosciences Announces FDA Orphan Drug Designation for TYRA-300 for the Treatment of Achondroplasia

Tyra Biosciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead precision medicine program, TYRA-300, for the treatment of achondroplasia.

August 1, 2023
·
7 min read
Business

Biosero Appoints Rob Harkness as Chief Technology Officer

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced the promotion of Rob Harkness, PhD, to the position of Chief Technology Officer.

August 1, 2023
·
3 min read
First Patients Outside of U.S. Treated with TRIA Polymer Surgical Mitral Heart Valve

Foldax® , Inc., a leader in the development of innovative, polymer heart valves, today announced that the first 30 patients have been treated outside of the U.S., in the Indian clinical trial of the TRIA™ surgical mitral heart valve.

August 1, 2023
·
3 min read
Pharm Country

Coeptis Therapeutics Files FDA 513(g) Submission for CD38 In Vitro Companion Diagnostic

Coeptis Therapeutics Holdings, Inc. announced that it has submitted a 513(g) request to the U.S. Food and Drug Administration (FDA) for an in vitro companion diagnostic test designed to be used with anti-CD38 monoclonal antibody therapies.

August 1, 2023
·
5 min read
Drug Development

ReAlta Life Sciences Doses First Patient in Phase 2 STAR-Study of RLS-0071 for Hypoxic Ischemic Encephalopathy in Newborns

ReAlta Life Sciences today announced dosing of the first patient in a Phase 2 clinical trial evaluating the safety and efficacy of RLS-0071 for the treatment of hypoxic ischemic encephalopathy (HIE) in newborns.

August 1, 2023
·
3 min read